GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 80.42 USD -0.06% Market Closed
Market Cap: 2.3B USD

Wall Street
Price Targets

WGS Price Targets Summary
GeneDx Holdings Corp

Wall Street analysts forecast WGS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WGS is 106.66 USD with a low forecast of 78.78 USD and a high forecast of 120.75 USD.

Lowest
Price Target
78.78 USD
2% Downside
Average
Price Target
106.66 USD
33% Upside
Highest
Price Target
120.75 USD
50% Upside
GeneDx Holdings Corp Competitors:
Price Targets
4544
H.U. Group Holdings Inc
5% Downside
PRDA
Prodia Widyahusada Tbk PT
2% Upside
FLGT
Fulgent Genetics Inc
28% Upside
DNTL
dentalcorp Holdings Ltd
58% Upside
KRSNAA
Krsnaa Diagnostics Ltd
23% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
4% Upside
CCRN
Cross Country Healthcare Inc
47% Upside
CCEL
Cryo-Cell International Inc
79% Upside

Revenue
Forecast

Revenue Estimate
GeneDx Holdings Corp

For the last 5 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 9%. The projected CAGR for the next 3 years is 19%.

9%
Past Growth
19%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
67%
Average Beat

Net Income
Forecast

Net Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WGS's stock price target?
Price Target
106.66 USD

According to Wall Street analysts, the average 1-year price target for WGS is 106.66 USD with a low forecast of 78.78 USD and a high forecast of 120.75 USD.

What is GeneDx Holdings Corp's Revenue forecast?
Projected CAGR
19%

For the last 5 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 9%. The projected CAGR for the next 3 years is 19%.

Back to Top